Cancer Care Ontario | Cancer Care Ontario

15 Results

Guidelines and Advice

Multidisciplinary Cancer Conference Standards

Status: Current
ID: MCC

Jun 2006

Guidelines and Advice

The Role of Trastuzumab in Adjuvant and Neoadjuvant Therapy in Women with HER2/neu-overexpressing Breast Cancer

Status: Education and Information
ID: 1-24 Version 2
Version: 2

May 2006

Guidelines and Advice

The Role of Porfimer Sodium (PhotofrinTM) in the Palliative Treatment of Esophageal Cancer

Status: Archived
ID: CED 3

Jan 2006

Guidelines and Advice

The Role of Porfimer Sodium (PhotofrinTM) in the Ablation of High-Grade Dysplasia in Barrett's Esophagus

Status: Archived
ID: CED 2
Version: 2

Jan 2006

Guidelines and Advice

The Use of Gabapentin and Tricyclic Antidepressants in the Treatment of Neuropathic Pain in Cancer Patients

Status: Archived
ID: 13-8

Oct 2006

Guidelines and Advice

Target Wait Times for Cancer Surgery in Ontario

Status: Current
ID: GL-C50-03

Apr 2006

Guidelines and Advice

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Status: Current

Mar 2025

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Mar 2025

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Status: Current
ID: PET 2024-1

Mar 2025

Guidelines and Advice

Effective Teaching Strategies and Methods for Cancer Patient Education

Status: Current
ID: GL 20-2
Version: 2

Updated

Apr 2025

Guidelines and Advice

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Status: Current
ID: GL 2-33
Version: 2

Updated

Jun 2025

Guidelines and Advice

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Status: Current
ID: GL 17-10 v2
Version: 2

Mar 2025

Multidisciplinary Cancer Conference Standards

The Role of Trastuzumab in Adjuvant and Neoadjuvant Therapy in Women with HER2/neu-overexpressing Breast Cancer

The Role of Porfimer Sodium (PhotofrinTM) in the Palliative Treatment of Esophageal Cancer

The Role of Porfimer Sodium (PhotofrinTM) in the Ablation of High-Grade Dysplasia in Barrett's Esophagus

The Use of Gabapentin and Tricyclic Antidepressants in the Treatment of Neuropathic Pain in Cancer Patients

Target Wait Times for Cancer Surgery in Ontario

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Effective Teaching Strategies and Methods for Cancer Patient Education

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Pages